The RACE Act of 2025 streamlines the process for companies to automatically qualify for selling substantially similar securities up to a $\$5$ million limit, provided prior filings and conditions are met.
Garland "Andy" Barr
Representative
KY-6
The RACE Act of 2025 streamlines the process for companies to offer new, substantially similar securities by allowing for automatic qualification if certain conditions are met. This provision applies to offerings under a specific exemption of the Securities Act of 1933, provided the new offering does not exceed a $5 million threshold. The goal is to expedite capital raising for closely related securities issuances.
The new Regulation Advancement for Capital Enhancement Act of 2025 (RACE Act) is looking to put the pedal down on how certain companies raise money. Specifically, Section 2 introduces a fast-track system for selling new securities, provided they look a lot like something the company has already sold.
Think of this as the express lane at the DMV for corporate fundraising. If a company has successfully used a specific exemption under the Securities Act of 1933 (paragraph 2) to sell a class of securities, they can now get their next offering automatically qualified simply by filing the paperwork, without the usual lengthy review. This Automatic Qualification is designed to save time and cut down on regulatory red tape for established issuers. For a small company that needs to quickly raise $3 million to expand operations or launch a new product line, this could shave weeks or even months off the process.
There are a few key speed bumps, though. First, the new offering can't be for more than $5,000,000. Second, the total amount raised under this specific exemption over the last 12 months can't exceed the overall annual limit. The biggest detail, however, lies in the term "substantially similar." The new securities don't have to be identical to the original ones in every way—they just need to share some predefined characteristics. For example, if a tech startup previously sold preferred stock with a 5% dividend, they could potentially use this fast track to sell new preferred stock with a 6% dividend, arguing it's still "substantially similar."
For the companies raising capital, this is a clear win for efficiency. For the rest of us—especially those who might invest in these offerings—it introduces a bit of a gray area. The whole point of regulatory review is to ensure that investors have all the necessary information about risk before putting money down. By allowing automatic qualification based on the subjective term "substantially similar," the bill reduces the level of direct regulatory scrutiny on these subsequent offerings. While the $5 million cap keeps things relatively small, it creates a potential loophole. A company could make several offerings just under that $5 million cap, constantly introducing slight variations that might carry different risks, but still bypass the full, comprehensive review. In essence, the efficiency gained by the issuer comes at the cost of reduced oversight for the investor, relying heavily on the issuer's good faith interpretation of what is "substantially similar" to a previous, approved security.